The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on May 4, 2026

May 4, 2026

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

May 4, 2026

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

May 4, 2026

CPS Technologies Announces First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Norwegian Cruise Line Holdings Ltd. Investigated for Securities Fraud Violations by Block & Leviton: NCLH Investors Should Contact the Firm to Possibly Recover Losses

Indeterminate GlobeNewswire

May 4, 2026

Sophos Celebrates 22 Leaders Named to 2026 CRN Women of the Channel List

Indeterminate GlobeNewswire

May 4, 2026

Polar ID kills the cutout — Metalenz launches simple, secure, face authentication working under the phone display

Indeterminate GlobeNewswire

May 4, 2026

Stop & Shop Expands Grocery Delivery for Customers with Uber Eats

Indeterminate GlobeNewswire

May 4, 2026

Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026

Indeterminate GlobeNewswire

May 4, 2026

Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants

Indeterminate GlobeNewswire

May 4, 2026

Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET

Indeterminate GlobeNewswire

May 4, 2026

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

Indeterminate GlobeNewswire

May 4, 2026

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Indeterminate GlobeNewswire

May 4, 2026

Ahold Delhaize USA Brands Expand On-Demand Grocery Delivery with Uber Eats

Indeterminate GlobeNewswire

May 4, 2026

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

Indeterminate GlobeNewswire

May 4, 2026

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

Indeterminate GlobeNewswire

May 4, 2026

Emerging Drugs Market to Reach $558.0 Billion by 2030, Driven by Biologics Innovation and Regulatory Support

Indeterminate GlobeNewswire

May 4, 2026

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

Indeterminate GlobeNewswire

May 4, 2026

Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

May 4, 2026

Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

Indeterminate GlobeNewswire

May 4, 2026

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

Indeterminate GlobeNewswire